Hygromycin A Treatment of Borrelia burgdorferi-Infected Peromyscus leucopus Suggests Potential as a Reservoir-Targeted Antibiotic

J Infect Dis. 2026 Jan 17;233(1):96-100. doi: 10.1093/infdis/jiaf363.

Abstract

Lyme disease spirochetes are maintained in natural reservoirs before spilling over into human populations. Targeting these reservoirs with vaccinations or antibiotics could impact the Borrelia burgdorferi enzootic cycle and reduce the risk of human Lyme disease. In this work we report that the narrow-spectrum antibiotic hygromycin A is sufficient to disrupt B burgdorferi transmission from the main eastern US reservoir, Peromyscus leucopus, to ticks. Additionally, hygromycin A-containing baits can clear B burgdorferi from P leucopus. These studies lay the foundation for the use of hygromycin A as a reservoir-targeted antibiotic to eradicate B burgdorferi in the wild.

Keywords: Borrelia burgdorferi; Borreliella burgdorferi; Lyme disease; antibiotics; reservoir.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / administration & dosage
  • Anti-Bacterial Agents* / pharmacology
  • Borrelia burgdorferi* / drug effects
  • Cinnamates
  • Disease Reservoirs / microbiology
  • Hygromycin B* / analogs & derivatives
  • Hygromycin B* / pharmacology
  • Hygromycin B* / therapeutic use
  • Lyme Disease* / drug therapy
  • Lyme Disease* / microbiology
  • Lyme Disease* / transmission
  • Lyme Disease* / veterinary
  • Peromyscus* / microbiology

Substances

  • Anti-Bacterial Agents
  • Hygromycin B
  • hygromycin A
  • Cinnamates